Enzymatica AB

The Board of Directors of Enzymatica AB decides on rights issue of SEK 98.7 million - Seite 2

Terms and conditions in brief

Under the terms of the rights issue, seven (7) existing shares carry the right to subscribe for four (4) new shares at a price of SEK 1.90 per share. The rights issue is 28.8 percent covered by subscription commitments from board members, management and a number of the company's major shareholders. In addition, the company has entered into underwriting agreements with two major shareholders of SEK 46.9 million, equivalent to 47.5 percent of the right issue. In total, the right issue comprises of 76.3 percent of subscription commitments and underwriting agreements.

The Board of Directors intends to secure the rights issue to 100 percent through subscription commitments and underwriting agreements. Assuming full subscription, Enzymatica will raise SEK 98,678,187.20 before issue expenses.

One (1) existing share in Enzymatica carries one (1) subscription right, while seven (7) subscription rights entitle the holder to subscribe to four (4] new shares. The share capital will therefore increase by a maximum of SEK 2,077,436.20 and the number of shares by a maximum of 51,935,888 shares. The subscription price is SEK 1.90 per share.

The record date at Euroclear Sweden AB for participation in the rights issue is November 12, 2018.

The subscription period will run from and including November 14, 2018 up to and including November 28, 2018.

Subscription rights not exercised by that date will expire and will lose their value. Trading in subscription rights will take place on Nasdaq First North from and including November 14, 2018 up to and including November 26, 2018.

If not all the shares are subscribed for by exercise of subscription rights, the Board of Directors shall resolve on allotment of shares subscribed for without the exercise of subscriptions rights up to the maximum amount of the share issue. Such shares shall in firstly be allotted to those who have also subscribed for shares by exercise of subscription rights, regardless of them being shareholders on the record date or not, pro rata in relation to the number of subscription rights which each person has exercised for subscription. Secondly, such shares shall be allotted to members of the management group who have applied for subscription without the exercise of subscription rights, and thirdly to others, pro rata in relation to their applied interest. To the extent that allotment in accordance to the above cannot be made pro rata, allotment shall be made by drawing of lots. Any remaining shares shall be allotted to those who have guaranteed the new share issue, pro rata in relation to the guaranteed amount.